Nanomedicine-encouraged cellular autophagy promoters favor liver fibrosis progression reversal

Abstract

Liver fibrosis is a major risk factor for hepatocellular carcinoma origin, and its progression not only correlates with oxidative stress and inflammation, but also is encouraged by autophagy hold-up. Therefore, new solutions to effectively attenuate oxidative stress and inflammation and coincidently favor autophagy are highly demanded to reverse liver fibrosis, and even hamper its escalation into hepatocellular carcinoma. Herein, the porous manganese-substituted Prussian blue (PMPB) analogs are harnessed to activate autophagy, scavenge reactive oxygen species (ROS), and suppress inflammation for liver fibrosis therapy. PMPB can effectively inhibit macrophage activation, facilitate macrophage autophagy, eradicate ROS, and blockade cellular cross-talk, thus impeding further inflammation progression. Moreover, the favorable spontaneous capture of PMPB by Kupffer cells allows more PMPB accumulation in liver to significantly attenuate liver injury and collagen deposition, thereby inhibiting the progression of liver fibrosis. PMPB-based nanomedicine shows great potentials in promoting autophagy activation, eliminating ROS, inhibiting inflammation, and protecting hepatocytes from oxidative stress-arised damages, which eventually attenuate the extent of liver fibrosis, holding great promise in clinical translation for treating liver fibrosis.

Keywords

anti-inflammation / autophagy / liver fibrosis / oxidation stress / Prussian blue analog

References

[1] P. Burra, Minerva Gastroenterol. 2021, 67, 2.

[2] D. Wang, J. Zhou, R. Chen, R. Shi, G. Xia, S. Zhou, Z. Liu, N. Zhang, H. Wang, Z. Guo, Q. Chen, Biomaterials 2016, 107, 88.

[3] M. Parola, M. Pinzani, Mol. Aspects Med. 2019, 65, 37.

[4] P. Marcellin, B. K. Kutala, Liver Int. 2018, 38, 2.

[5] L. Lu, T. Wang, C. Fang, L. Song, C. Qian, Z. Lv, Y. Fang, X. Liu, X. Yu, X. Xu, C. Su, F. Chen, K. Zhang, ACS Appl. Mater. Interfaces 2022, 14, 36462.

[6] C. Fang, G. Xiao, T. Wang, L. Song, B. Peng, B. Xu, K. Zhang, Research 2023, 6, 0108.

[7] Y. Zhang, D. Du, C. Fang, X. Yu, Y. Fang, X. Liu, D. Ou, H. Yin, H. Liu, T. Wang, L. Lu, X. Li, K. Zhang, Fundam. Res. 2022 https://doi.org/10.1016/j.fmre.2022.06.020.

[8] A. R. Anzell, R. Maizy, K. Przyklenk, T. H. Sanderson, Mol. Neurobiol. 2018, 55, 2547.

[9] J. Zhou, X. Y. Li, Y. J. Liu, J. Feng, Y. Wu, H. M. Shen, G. D. Lu, Autophagy 2022, 18, 1240.

[10] J. Guo, Z. Zhao, Z. F. Shang, Z. Tang, H. Zhu, K. Zhang, Exploration 2023, 3, 20220119.

[11] L. Song, L. Lu, Y. Pu, H. Yin, K. Zhang, Accounts Mater.Res. 2022, 3, 971.

[12] L. C. Wang, P. Y. Chiou, Y. P. Hsu, C. L. Lee, C. H. Hung, Y. H. Wu, W. J. Wang, G. L. Hsieh, Y. C. Chen, L. C. Chang, W. P. Su, D. Manoharan, M. C. Liao, S. Thangudu, W. P. Li, C. H. Su, H. K. Tian, C. S. Yeh, Nat. Commun. 2023, 14, 4709.

[13] Y. Zhang, C. Fang, W. Zhang, K. Zhang, Matter 2022, 5, 3740.

[14] J. P. Zhong, X. Yang, S. Z. Gao, J. Luo, J. H. Xiang, G. H. Li, Y. L. Liang, L. J. Tang, C. Qian, J. Zhou, L. Zheng, K. Zhang, J. M. Zhao, Adv. Funct. Mater. 2023, 33, 2209399.

[15] J. Zhou, C. Fang, C. Rong, T. Luo, J. Liu, K. Zhang, SmartMater. Med. 2023, 4, 427.

[16] M. Yang, Y. Zhang, C. Fang, L. Song, Y. Wang, L. Lu, R. Yang, Z. Bu, X. Liang, K. Zhang, Q. Fu, Adv. Mater. 2022, 34, 2109522.

[17] H. Cao, L. Duan, Y. Zhang, J. Cao, K. Zhang, Signal Transduct. Target Ther. 2021, 6, 426.

[18] Q. Zhang, L. Song, K. Zhang, Mat. Chem. Front. 2022, 7, 44.

[19] S. Yazdani, R. Bansal, J. Prakash, Adv. Drug. Deliv. Rev. 2017, 121, 101.

[20] H. Jia, J. Liu, T. Fang, Z. Zhou, R. Li, W. Yin, Y. Qian, Q. Wang, W. Zhou, C. Liu, D. Sun, X. Chen, Z. Ouyang, J. Dong, Y. Wang, S. Yue, Sci. Adv. 2023, 9, eabq2937.

[21] T. Kisseleva, D. Brenner, Nat. Rev. Gastroenterol. Hepatol. 2021, 18, 151.

[22] D. Oro, T. Yudina, G. Fernandez-Varo, E. Casals, V. Reichenbach, G. Casals, B. Gonzalez de la Presa, S. Sandalinas, S. Carvajal, V. Puntes, W. Jimenez, J. Hepatol. 2016, 64, 691.

[23] X. Bai, G. Su, S. Zhai, Nanomaterials 2020, 10, 1945.

[24] A. Adhikari, N. Polley, S. Darbar, D. Bagchi, S. K. Pal, Future Sci. OA 2016, 2, FSO146.

[25] J. Zhao, X. Cai, W. Gao, L. Zhang, D. Zou, Y. Zheng, Z. Li, H. Chen, ACS Appl. Mater. Interfaces 2018, 10, 26108.

[26] Y. Zhang, Y. Yin, W. Zhang, H. Li, T. Wang, H. Yin, L. Sun, C. Su, K. Zhang, H. Xu, J. Nanobiotechnol. 2021, 19, 161.

[27] H. Yin, B. Zhou, C. Dong, Y. Zhang, J. Yu, Y. Pu, W. Feng, L. Sun, H. Hu, Y. Chen, H. Xu, Adv. Funct. Mater. 2021, 31, 2107093.

[28] Y. Koyama, D. A. Brenner, J. Clin. Invest. 2017, 127, 55.

[29] K. Zhang, M. Tu, W. Gao, X. Cai, F. Song, Z. Chen, Q. Zhang, J. Wang, C. Jin, J. Shi, X. Yang, Y. Zhu, W. Gu, B. Hu, Y. Zheng, H. Zhang, M. Tian, Nano Lett. 2019, 19, 2812.

[30] T. Zhou, X. Yang, Z. Chen, Y. Yang, X. Wang, X. Cao, C. Chen, C. Han, H. Tian, A. Qin, J. Fu, J. Zhao, Adv. Sci. 2022, 9, 2105466.

[31] Y. Zou, B. Jin, H. Li, X. Wu, Y. Liu, H. Zhao, D. Zhong, L. Wang, W. Chen, M. Wen, Y. N. Liu, ACS Nano 2022, 16, 21491.

[32] X. N. Zhang, Q. Zhao, J. J. Yang, T. X. Wang, F. B. Chen, K. Zhang, Coord. Chem. Rev. 2023, 484, 215115.

[33] Y. Huang, L. Zhong, X. Li, P. Wu, J. He, C. Tang, Z. Tang, J. Su, Z. Feng, B. Wang, Y. Ma, H. Peng, Z. Bai, Y. Zhong, Y. Liang, W. Lu, R. Luo, J. Li, H. Li, Z. Deng, X. Lan, Z. Liu, K. Zhang, Y. Zhao, Adv. Mater. 2022, 34, 2109973.

[34] T. Wang, X. Zhang, Y. Xu, Y. Xu, Y. Zhang, K. Zhang, J. Mater. Chem. B 2022, 10, 7361.

[35] Q. Liu, W. Zhang, R. Jiao, Z. Lv, X. Lin, Y. Xiao, K. Zhang, Adv. Sci. 2022, 9, 2203921.

[36] X. Y. Liang, Y. Zhang, J. Zhou, Z. T. Bu, J. J. Liu, K. Zhang, Coord. Chem. Rev. 2022, 473, 214824.

[37] F. Kong, C. Fang, Y. Zhang, L. Duan, D. Du, G. Xu, X. Li, H. Li, Y. Yin, H. Xu, K. Zhang, Adv. Sci. 2022, 9, 2105523.

[38] M. Chen, H. Liao, Z. T. Bu, D. Wang, C. Fang, X. Y. Liang, H. Y. Li, J. J. Liu, K. Zhang, D. K. Su, Chem. Eng. J. 2022, 441, 136030.

[39] Y. A. Lee, M. C. Wallace, S. L. Friedman, Gut 2015, 64, 830.

[40] L. Lin, H. Gong, R. Li, J. Huang, M. Cai, T. Lan, W. Huang, Y. Guo, Z. Zhou, Y. An, Z. Chen, L. Liang, Y. Wang, X. Shuai, K. Zhu, Adv. Sci. 2020, 7, 1903138.

[41] T. Lan, C. Li, G. Yang, Y. Sun, L. Zhuang, Y. Ou, H. Li, G. Wang, T. Kisseleva, D. Brenner, J. Guo, Hepatology 2018, 68, 1070.

[42] W. Tang, Z. Zhao, Y. Chong, C. Wu, Q. Liu, J. Yang, R. Zhou, Z. X. Lian, G. Liang, ACS Nano 2018, 12, 9966.

[43] E. Roeb, Matrix Biol. 2018, 68, 463.

[44] T. Latronico, C. Mascia, I. Pati, P. Zuccala, F. Mengoni, R. Marocco, T. Tieghi, V. Belvisi, M. Lichtner, V. Vullo, C. M. Mastroianni, G. M. Liuzzi, Int. J. Mol. Sci. 2016, 17, 455.

[45] D. Ni, C. A. Ferreira, T. E. Barnhart, V. Quach, B. Yu, D. Jiang, W. Wei, H. Liu, J. W. Engle, P. Hu, W. Cai, J. Am. Chem. Soc. 2018, 140, 14971.

[46] D. Ni, D. Jiang, E. B. Ehlerding, P. Huang, W. Cai, Acc. Chem. Res. 2018, 51, 778.

[47] J. Gao, B. Wei, T. M. de Assuncao, Z. Liu, X. Hu, S. Ibrahim, S. A. Cooper, S. Cao, V. H. Shah, E. Kostallari, J. Hepatol. 2020, 73, 1144.

[48] S. Du, C. Li, Y. Lu, X. Lei, Y. Zhang, S. Li, F. Liu, Y. Chen, D. Weng, J. Chen, Theranostics 2019, 9, 1878.

[49] C. R. Brooks, M. Y. Yeung, Y. S. Brooks, H. Chen, T. Ichimura, J. M. Henderson, J. V. Bonventre, EMBO J. 2015, 34, 2441.

RIGHTS & PERMISSIONS

2024 2024 The Authors. View published by Shanghai Fuji Technology Consulting Co., Ltd, authorized by Professional Community of Experimental Medicine, National Association of Health Industry and Enterprise Management (PCEM) and John Wiley & Sons Australia, Ltd.